Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.05
+0.51 (1.32%)
Jan 17, 2025, 4:00 PM EST - Market closed
HRMY Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for HRMY stock have an average target of 55, with a low estimate of 40 and a high estimate of 75. The average target predicts an increase of 40.85% from the current stock price of 39.05.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HRMY stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 4 | 4 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +92.06% | Jan 16, 2025 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +33.16% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +92.06% | Dec 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $51 → $58 | Buy | Maintains | $51 → $58 | +48.53% | Oct 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $56 → $59 | Buy | Reiterates | $56 → $59 | +51.09% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
726.29M
from 582.02M
Increased by 24.79%
Revenue Next Year
864.26M
from 726.29M
Increased by 19.00%
EPS This Year
2.35
from 2.13
Increased by 10.35%
EPS Next Year
3.25
from 2.35
Increased by 38.44%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 753.1M | 934.3M | 1.2B | |||
| Avg | 726.3M | 864.3M | 1.1B | |||
| Low | 691.9M | 774.9M | 922.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 29.4% | 28.6% | 38.7% | |||
| Avg | 24.8% | 19.0% | 25.3% | |||
| Low | 18.9% | 6.7% | 6.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.55 | 4.37 | 6.32 | ||
| Avg | 2.35 | 3.25 | 4.83 | ||
| Low | 2.07 | 1.78 | 3.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.8% | 85.8% | 94.3% | ||
| Avg | 10.3% | 38.4% | 48.3% | ||
| Low | -2.9% | -24.1% | -3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.